StockSelector.com
  Research, Select, & Monitor Monday, April 06, 2020 1:44:47 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Haemonetics Corp.$102.06$3.663.72%

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Haemonetics Corp. has an overall rank of 779 out of 7173 stocks based on 17 positive rankings and 8 negative rankings.

Positive Rankings
Beat Whisper
According to EarningsWhispers.com, Haemonetics beat the Earnings Whisper number when it last reported earnings. Statistics show that companies that have beat the Earnings Whisper number outperform the market in the short-term.
Positive Guidance
Within the past 90 days Haemonetics has provided guidance above the consensus estimates. Statistics show companies that provide positive guidance outperform the market in the short-term.
Estimated EPS Growth
Haemonetics rank is 235
Top Industry Values
Haemonetics rank is 486
10 Day Gain
Haemonetics rank is 607
Up Ratings Revision
During the past month, the average analyst's rating or recommendation has increased. Among companies that have been upgraded within the past month, Haemonetics is ranked 664.
Up EPS Surprise
Haemonetics beat the consensus earnings estimate when it last reported quarterly earnings.
Highest Net Margin
Haemonetics rank is 1016
Low/Rising MACD
The MACD remains negative, but is rising... suggesting a possible near-term correction. Of companies with a negative, but rising MACD, Haemonetics is ranked 1218.
Target Prices
The average analysts' target price is $138.00 for Haemonetics using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, Haemonetics is ranked 1229.
Estimated Revenue Growth
Haemonetics rank is 1230
SSValue
The StockSelector Value for Haemonetics is $133.21. The StockSelector Value assumes the market consistently prices a stock around a given PE ratio and, therefore, multiplies the average PE (using forward earnings estimates) over the past three years by future earnings estimates. Among companies with a StockSelector Value above the current stock price, Haemonetics is ranked 1380.
Highest ROA
Haemonetics rank is 1380
Debt-to-Equity
Haemonetics rank is 1561
Historic EPS Growth
Haemonetics rank is 1745
Highest ROE
Haemonetics rank is 1923
Historic Revenue Growth
Haemonetics rank is 2740
Negative Rankings
Price-to-Book
Haemonetics rank is 372
Overbought Stochastics
Haemonetics rank is 546
High Put/Call
Haemonetics has a high Put/Call ratio of 1.45 on all open interest of options expiring in the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Haemonetics is ranked 577.
Price-to-Sales
Haemonetics rank is 716
Down Estimate Revision
During the past month, the consensus earnings estimate for the current year and next year have decreased by a combined (3.59%). Among companies that have had their estimates lowerec within the past month, Haemonetics is ranked 1126.
Negative Cash Growth
Haemonetics rank is 1568
High vPut/Call
Haemonetics has a high Put/Call ratio of 0.55 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Haemonetics is ranked 2160.
90 Day Loss
Haemonetics rank is 3753







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2020 StockSelector.com. All rights reserved.